A Machine Learning approach for assessing drug development risk
Vangelis Vergetis, Gerasimos Liaropoulos, Maria Georganaki, Andreas Dimakakos, Dimitrios Skaltsas, Vassilis G. Gorgoulis, Aristotelis Tsirigos
This paper proposes a machine learning approach to estimate drug development risk more accurately than traditional models.
bioRxiv · Oct 8, 2020 · PreprintBioinformatics